$ARRT
Artisan Consumer Goods, Inc.

2022 Q3 Form 10-K Financial Statement

#000147793222007358 Filed on September 30, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue $865.00 $0.00 $0.00
YoY Change
Cost Of Revenue $434.00 $0.00
YoY Change
Gross Profit $431.00 $0.00
YoY Change
Gross Profit Margin 49.83%
Selling, General & Admin $20.61K $3.330K $30.00K
YoY Change 36.31% 455.0%
% of Gross Profit 4781.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $750.00 $750.00 $0.00
YoY Change 19.05%
% of Gross Profit 174.01%
Operating Expenses $21.36K $4.080K $30.30K
YoY Change 35.63% 591.53% -989.0%
Operating Profit -$20.93K -$30.30K
YoY Change 32.9% -989.0%
Interest Expense $8.225K
YoY Change
% of Operating Profit
Other Income/Expense, Net $15.00 -$40.00 -$8.240K
YoY Change -99.41% -121.05% -169.03%
Pretax Income -$20.91K -$12.34K -$40.00K
YoY Change 58.53% -203.35% -300.0%
Income Tax
% Of Pretax Income
Net Earnings -$20.91K -$12.34K -$38.54K
YoY Change 58.54% -203.35% -351.15%
Net Earnings / Revenue -2417.57%
Basic Earnings Per Share
Diluted Earnings Per Share -$4.752K -$2.805K -$9.091K
COMMON SHARES
Basic Shares Outstanding 4.400M shares 4.400M shares
Diluted Shares Outstanding 4.400M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.480K $13.56K $10.00K
YoY Change -88.48% 1406.67%
Cash & Equivalents $3.483K $13.56K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $7.923K $8.224K $10.00K
Prepaid Expenses
Receivables $508.00 $0.00
Other Receivables $0.00
Total Short-Term Assets $11.91K $21.78K $20.00K
YoY Change -60.54% 2317.2%
LONG-TERM ASSETS
Property, Plant & Equipment $5.375K $6.125K
YoY Change
Goodwill
YoY Change
Intangibles $1.000K $1.000K
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.375K $7.125K $10.00K
YoY Change -32.0%
TOTAL ASSETS
Total Short-Term Assets $11.91K $21.78K $20.00K
Total Long-Term Assets $6.375K $7.125K $10.00K
Total Assets $18.29K $28.90K $30.00K
YoY Change -53.78% 3107.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.19K $45.69K $50.00K
YoY Change 59.39% 41.23% 66.67%
Accrued Expenses $48.27K $48.29K $50.00K
YoY Change 5.59% 0.03% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $154.2K $154.2K $150.0K
YoY Change 0.0% 50.46% 50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $257.7K $248.2K $250.0K
YoY Change 9.86% 35.53% 38.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $257.7K $248.2K $250.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $257.7K $248.2K $250.0K
YoY Change 9.86% 35.53% 38.89%
SHAREHOLDERS EQUITY
Retained Earnings -$19.24M -$19.22M
YoY Change 0.24% 0.2%
Common Stock $4.400K $4.400K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$239.4K -$219.3K -$220.0K
YoY Change
Total Liabilities & Shareholders Equity $18.29K $28.90K $30.00K
YoY Change -53.78% 3107.99%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$20.91K -$12.34K -$38.54K
YoY Change 58.54% -203.35% -351.15%
Depreciation, Depletion And Amortization $750.00 $750.00 $0.00
YoY Change 19.05%
Cash From Operating Activities -$10.07K -$3.390K -$29.07K
YoY Change -18.94% 118.71% 100.34%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$10.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$10.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 $51.72K
YoY Change -100.0% 417.19%
NET CHANGE
Cash From Operating Activities -$10.07K -3.390K -$29.07K
Cash From Investing Activities $0.00 0.000 -$10.00K
Cash From Financing Activities $0.00 0.000 $51.72K
Net Change In Cash -$10.07K -3.390K $12.65K
YoY Change -134.38% 118.71% -380.7%
FREE CASH FLOW
Cash From Operating Activities -$10.07K -$3.390K -$29.07K
Capital Expenditures $0.00 $0.00 -$10.00K
Free Cash Flow -$10.07K -$3.390K -$19.07K
YoY Change 315.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Professional Fees
ProfessionalFees
24071 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
20490 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
-3408 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
901 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
4400 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
4400 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18984200 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18984200 usd
CY2022Q2 arrt Stock To Be Issued
StockToBeIssued
7543 usd
CY2021Q2 arrt Stock To Be Issued
StockToBeIssued
6073 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19215426 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19176889 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-219283 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-182216 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28904 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
901 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1470 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
-24520 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1881 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
622 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2875 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
30297 usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001530425
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 usd
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4400048 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4400048 shares
CY2015Q1 arrt Monthly Fee
MonthlyFee
15000 usd
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14286 shares
CY2016Q4 arrt Fair Value Of Shares
FairValueOfShares
3200 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022 dei Entity File Number
EntityFileNumber
000-54838
CY2022 dei Entity Registrant Name
EntityRegistrantName
ARTISAN CONSUMER GOODS, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1240056
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
999 N Northlake Way Ste 203
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98103-3442
CY2022 dei City Area Code
CityAreaCode
206
CY2022 dei Local Phone Number
LocalPhoneNumber
517-7141
CY2022 dei Security12b Title
Security12bTitle
Common
CY2022 dei Trading Symbol
TradingSymbol
ARRT
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
162000 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4400048 shares
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Name
AuditorName
BF Borgers
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood
CY2022Q2 us-gaap Inventory Net
InventoryNet
8224 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2875 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
45685 usd
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
32349 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48286 usd
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48271 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
154216 usd
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
102497 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
248187 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
183117 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-30297 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
3408 usd
CY2022 us-gaap Other Income
OtherIncome
15 usd
CY2021 us-gaap Other Income
OtherIncome
414 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12350 usd
CY2022 arrt Impairment Expense
ImpairmentExpense
-8225 usd
CY2021 arrt Impairment Expense
ImpairmentExpense
0 usd
CY2022 arrt Basic And Diluted Income Loss Per Share
BasicAndDilutedIncomeLossPerShare
-0.01
CY2021 arrt Basic And Diluted Income Loss Per Share
BasicAndDilutedIncomeLossPerShare
0.00
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4400048 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4400048 shares
CY2020 arrt Common Stock To Be Issued
CommonStockToBeIssued
910 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-21723 usd
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-173040 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
-24520 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
15344 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-182216 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1470 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-38537 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-219283 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-38537 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
15344 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2875 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1470 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
-24520 usd
CY2022 us-gaap Interest Expense
InterestExpense
8225 usd
CY2021 us-gaap Interest Expense
InterestExpense
0 usd
CY2022 arrt Fair Value Adjustment For Shares Issued From Settlement Agreement
FairValueAdjustmentForSharesIssuedFromSettlementAgreement
15 shares
CY2021 arrt Fair Value Adjustment For Shares Issued From Settlement Agreement
FairValueAdjustmentForSharesIssuedFromSettlementAgreement
414 shares
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12350 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
901 usd
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5409 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13555 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
901 usd
CY2020Q3 arrt Shares Valued Per Share
SharesValuedPerShare
0.51
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company provides estimates for its common stock valuations and valuation allowances for deferred taxes.</p>
CY2022 arrt Cash Flow Reporting Policy Textblock
CashFlowReportingPolicyTextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company follows ASC 230, Statement of Cash Flows, for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.</p>
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
366 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8825 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
8224 usd
CY2021Q2 us-gaap Inventory Net
InventoryNet
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1470 usd
CY2020Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
50000 shares
CY2020Q3 arrt Unissued Shares Valued
UnissuedSharesValued
25500 usd
CY2022 arrt Income Tax Rate Maximum
IncomeTaxRateMaximum
0.350 pure
CY2022 arrt Income Tax Rate Minimum
IncomeTaxRateMinimum
0.210 pure
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19215426 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.21 pure
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2875 usd
CY2016Q3 arrt Payment In Cash
PaymentInCash
50000 usd
CY2016Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
144216 usd
CY2017Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
10000 usd
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
154216 usd
CY2021Q2 us-gaap Due From Related Parties
DueFromRelatedParties
102497 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.21 pure
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4035239 usd
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4027147 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4035239 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4027147 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd

Files In Submission

Name View Source Status
0001477932-22-007358-index-headers.html Edgar Link pending
0001477932-22-007358-index.html Edgar Link pending
0001477932-22-007358.txt Edgar Link pending
0001477932-22-007358-xbrl.zip Edgar Link pending
arrt-20220630.xsd Edgar Link pending
arrt_10k.htm Edgar Link pending
arrt_ex311.htm Edgar Link pending
arrt_ex312.htm Edgar Link pending
arrt_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
arrt-20220630_cal.xml Edgar Link unprocessable
arrt-20220630_def.xml Edgar Link unprocessable
arrt-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arrt-20220630_pre.xml Edgar Link unprocessable
arrt_10k_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending